Home » Prices » NASDAQ:CBAY

CymaBay Therapeutics, Inc. stock price

Today's NASDAQ:CBAY chart, history & news

Price:
7.46 USD
Change:
+0.2 (2.76%)
Key Stats
Price open 7.21
Previous close 7.26
Market cap 513.90M
Volume 523.41K
Day high 7.5
Day low 7.17
Year high 9.03
Year low 1.25
Year to date change 287.29%
P/E Ratio N.A
Company Profile
Fundamentals
Insider Information
News

About CymaBay Therapeutics, Inc.

CymaBay Therapeutics, Inc. is a clinical stage biopharmaceutical company, focused on developing and providing access to therapies for patients with liver and other chronic diseases with high unmet medical need. Its products include MBX-8025 and Arhalofenate, MBX-8025 aims to treat lipid and liver diseases while Arhalofenate intends to reduce gout flares and serum uric acid. The company was founded on October 5, 1988 and is headquartered in Newark, CA.

Company information

Company name
Cymabay Therapeutics Inc
Exchange
Sector
Health Technology
Industry
Biotechnology
Employees
60
CEO
Sujal Shah
Address
7575 Gateway Boulevard, Newark, CA, 94560
Country
United States
Contact information
1.510.293.8800
Website
http://www.cymabay.com

Related companies

Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.